Christopher K. Arnatt

715 total citations
46 papers, 543 citations indexed

About

Christopher K. Arnatt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Christopher K. Arnatt has authored 46 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 9 papers in Organic Chemistry. Recurrent topics in Christopher K. Arnatt's work include Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (11 papers) and Estrogen and related hormone effects (9 papers). Christopher K. Arnatt is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (11 papers) and Estrogen and related hormone effects (9 papers). Christopher K. Arnatt collaborates with scholars based in United States, Belgium and Italy. Christopher K. Arnatt's co-authors include Yan Zhang, David Q.‐H. Wang, Yunyun Yuan, Dana E. Selley, Kurt F. Hauser, Nazira El‐Hage, Li Guo, Seth M. Dever, Yan Zhang and Ryan D. McCulla and has published in prestigious journals such as Journal of Clinical Investigation, Analytical Chemistry and Hepatology.

In The Last Decade

Christopher K. Arnatt

44 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher K. Arnatt United States 17 277 131 100 91 69 46 543
Margaret E. Olson United States 19 384 1.4× 63 0.5× 91 0.9× 40 0.4× 78 1.1× 32 797
Ambrish Saxena Germany 11 331 1.2× 47 0.4× 81 0.8× 53 0.6× 23 0.3× 16 554
Esther Y. Chao United States 11 546 2.0× 68 0.5× 80 0.8× 165 1.8× 132 1.9× 15 881
Thomas Bara United States 12 388 1.4× 91 0.7× 134 1.3× 50 0.5× 140 2.0× 12 854
Val S. Goodfellow United States 17 371 1.3× 74 0.6× 47 0.5× 15 0.2× 146 2.1× 28 802
Christopher Moxham United States 9 487 1.8× 63 0.5× 47 0.5× 30 0.3× 153 2.2× 15 734
Michael L. Vazquez United States 15 189 0.7× 53 0.4× 49 0.5× 83 0.9× 216 3.1× 21 537
Sangeeta Raje United States 15 203 0.7× 79 0.6× 122 1.2× 10 0.1× 39 0.6× 26 535
Brooke M. Katzman United States 12 186 0.7× 90 0.7× 78 0.8× 13 0.1× 49 0.7× 26 406
Joan R. Kanter United States 13 547 2.0× 72 0.5× 67 0.7× 59 0.6× 82 1.2× 16 757

Countries citing papers authored by Christopher K. Arnatt

Since Specialization
Citations

This map shows the geographic impact of Christopher K. Arnatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher K. Arnatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher K. Arnatt more than expected).

Fields of papers citing papers by Christopher K. Arnatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher K. Arnatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher K. Arnatt. The network helps show where Christopher K. Arnatt may publish in the future.

Co-authorship network of co-authors of Christopher K. Arnatt

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher K. Arnatt. A scholar is included among the top collaborators of Christopher K. Arnatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher K. Arnatt. Christopher K. Arnatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Natale, Christopher A., Israel Olayide, Christopher K. Arnatt, et al.. (2025). LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical Development. Cancer Research Communications. 5(4). 556–568.
2.
Pyles, Kelly D., et al.. (2024). Double Cyclization Tandem Mass for Identification and Quantification of Phosphatidylcholines Using Isobaric Six-Plex Capillary nLC-MS/MS. Journal of the American Society for Mass Spectrometry. 35(7). 1403–1412. 1 indexed citations
3.
Giancotti, Luigino Antonio, et al.. (2024). 12-(S)-Hydroxyeicosatetraenoic Acid and GPR31 Signaling in Spinal Cord in Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 388(3). 765–773. 2 indexed citations
4.
Cho, Kevin, et al.. (2024). Discovery and Identification of Three Homocysteine Metabolites by Chemical Derivatization and Mass Spectrometry Fragmentation. Analytical Chemistry. 96(29). 11639–11643. 2 indexed citations
5.
Salvemini, Daniela, et al.. (2023). Development of GPR183 antagonists to treat neuropathic pain. Journal of Pharmacology and Experimental Therapeutics. 385. 364–364.
6.
Arnatt, Christopher K., et al.. (2022). Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons. eNeuro. 9(4). ENEURO.0475–21.2022. 17 indexed citations
7.
Arnatt, Christopher K., et al.. (2021). Neutron encoded derivatization of endothelial cell lysates for quantitation of aldehyde metabolites using nESI-LC-HRMS. Analytica Chimica Acta. 1190. 339260–339260. 12 indexed citations
8.
Giancotti, Luigino Antonio, Zhoumou Chen, Bonne M. Thompson, et al.. (2020). GPR183-Oxysterol Axis in Spinal Cord Contributes to Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 375(2). 367–375. 21 indexed citations
9.
Wang, Helen H., Ornella de Bari, Christopher K. Arnatt, et al.. (2020). Activation of Estrogen Receptor G Protein–Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice. Hepatology. 72(6). 2077–2089. 27 indexed citations
10.
Wang, David Q.‐H., et al.. (2020). G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases. Frontiers in Endocrinology. 11. 578536–578536. 19 indexed citations
11.
Wang, Helen H., et al.. (2020). A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice. Journal of Lipid Research. 61(5). 767–777. 19 indexed citations
12.
Arnatt, Christopher K., Yunyun Yuan, Ruturaj Masvekar, et al.. (2016). Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization. Bioorganic & Medicinal Chemistry. 24(22). 5969–5987. 28 indexed citations
13.
Arnatt, Christopher K., et al.. (2014). Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents. Bioorganic & Medicinal Chemistry Letters. 24(10). 2319–2323. 19 indexed citations
14.
15.
Arnatt, Christopher K., Saheem A. Zaidi, Zhu Zhang, et al.. (2013). Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents. European Journal of Medicinal Chemistry. 69. 647–658. 11 indexed citations
16.
El‐Hage, Nazira, Seth M. Dever, Elizabeth M. Podhaizer, et al.. (2013). A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia. AIDS. 27(14). 2181–2190. 28 indexed citations
17.
18.
Yuan, Yunyun, Christopher K. Arnatt, Nazira El‐Hage, et al.. (2013). A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimer: binding affinity versus functional activities. MedChemComm. 4(5). 847–847. 32 indexed citations
19.
Arnatt, Christopher K. & Yan Zhang. (2012). Facile synthesis of 2,3,5,6-tetrabromo-4-methyl-nitrocyclohexa-2,5-dien-1-one, a mild nitration reagent. Tetrahedron Letters. 53(13). 1592–1594. 5 indexed citations
20.
Zhang, Feng, Christopher K. Arnatt, Yunyun Yuan, et al.. (2011). The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents. Bioorganic & Medicinal Chemistry Letters. 21(18). 5159–5163. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret E. Olson Breakdown of academic impact, for papers by Ambrish Saxena Breakdown of academic impact, for papers by Esther Y. Chao Breakdown of academic impact, for papers by Thomas Bara Breakdown of academic impact, for papers by Val S. Goodfellow Breakdown of academic impact, for papers by Christopher Moxham Breakdown of academic impact, for papers by Michael L. Vazquez Breakdown of academic impact, for papers by Sangeeta Raje Breakdown of academic impact, for papers by Brooke M. Katzman Breakdown of academic impact, for papers by Joan R. Kanter
Rankless by CCL
2026